Oncology and Hematology

Oncology and Hematology Clinical Practice

Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.

Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.

Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.

993

LikeLikedUnlike

31-45 of 339

Translating Evidence on TROP2-Directed ADCs Into Global Practice in Metastatic TNBC
MinuteCE®
Translating Evidence on TROP2-Directed ADCs Into Global Practice in Metastatic TNBC
- Tiffany Traina, MD
- Javier Cortes, MD, PhD
0.75 program credits
Novel Strategies for Managing EGFR-mutated mNSCLC: Expert Insights into the Latest Data and Recommendations
CME/CE
Novel Strategies for Managing EGFR-mutated mNSCLC: Expert Insights into the Latest Data and Recommendations
- Alexandria May, PharmD, BCPS
- Helena A. Yu, MD
- Vicki Sherry, DNP, ANP-BC, AOCNP
1.00 credits
MinuteCE®
Redefining First-Line Therapy of Metastatic TNBC: Integrating TROP2-Directed ADCs Into Modern Treatment Strategy
- Tiffany Traina, MD
- Javier Cortes, MD, PhD
0.75 credits 6 episodes
What’s Next for TROP2-Directed ADCs in TNBC?
MinuteCE®
What’s Next for TROP2-Directed ADCs in TNBC?
- Tiffany Traina, MD
0.75 program credits
Managing Adverse Events Associated With TROP2-Directed ADCs in Metastatic TNBC
MinuteCE®
Managing Adverse Events Associated With TROP2-Directed ADCs in Metastatic TNBC
- Tiffany Traina, MD
0.75 program credits
CME/CE In-Person & Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026
Houston, Texas
1.00 credits
advertisement
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
- Susana Campos, MD, MPH
- Robert Coleman, MD, FACOG
- Debra Richardson, MD
1.00 credits
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
CME/CE
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
CME/CE
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
ADT Intensification: The Evidence You Can’t Afford to Miss
MinuteCE®
ADT Intensification: The Evidence You Can’t Afford to Miss
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
Case: Implementing ADT Intensification in mHSPC
MinuteCE®
Case: Implementing ADT Intensification in mHSPC
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
advertisement
Targeting PTEN: Why It Matters
MinuteCE®
Targeting PTEN: Why It Matters
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
MinuteCE®
Treatment Intensification in HSPC: From Risk Stratification to Precision Medicine
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 credits 10 episodes
De Novo mHSPC: Recognizing the Patients Who Need More
MinuteCE®
De Novo mHSPC: Recognizing the Patients Who Need More
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits